Altimmune, Inc. (NASDAQ:ALT) Q1 2026 Earnings Call Transcript May 13, 2026
Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.25.
Operator: Good morning, ladies and gentlemen, and welcome to the Altimmune First Quarter 2026 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I’ll now introduce your host for today’s conference call, Luis Sanay, Vice President of Investor Relations. Luis, you may...
